
Jeanny Aragon-Ching, MD, Inova Schar Cancer Institute
Advertisement
Articles by Jeanny Aragon-Ching, MD, Inova Schar Cancer Institute
Advertisement
Latest Updated Articles
Increased Survival Outcomes with Switch Maintenance in mUCAugust 26th 2020
Changing the Standard of Care in Metastatic Bladder CancerAugust 26th 2020
Safety Data from JAVELIN Bladder 100August 26th 2020
Sequencing Considerations in mUC after Frontline IOAugust 26th 2020
Current Status of Therapy: Metastatic Urothelial CancerAugust 26th 2020
PD-L1 Expression in Metastatic Urothelial CancerAugust 26th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer
2
FDA Grants Accelerated Approval to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy
3
Five Under 5: Top Oncology Videos for the Week of 8/2
4
Revisit Every OncLive On Air Episode From July 2026
5











